Ault Milton C III

Director, 10% OwnerAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Sep 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$227K
Net Open-Market Flow
-$227K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2025Conversion(C)100K$2.32$232K111K
Sep 25, 2025Sell(S)15K$2.31$34K11K
Sep 24, 2025Sell(S)39K$2.31$90K26K
Sep 23, 2025Sell(S)43K$2.38$103K65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 25, 2025Conversion(C)232$1000.00$232K839

Transaction Codes

C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-014210) within minutes of acceptance. Every field above traces to the original document. Verify it directly: